Jin Jiafei*
Every bone in the body can develop into bone cancer, but the pelvis or the long bones in the arms and legs are the most frequently affected. Less than 1% of all cancer cases are bone cancer, making it an uncommon disease. Bone tumours that are not malignant are really considerably more prevalent than those that are. Cancers that start in other parts of the body and spread (metastasize) to the bones are not included in the phrase "bone cancer". Instead, those malignancies are given names based on where they first manifested, such as bone metastasizing breast cancer. The most typical indication of bone cancer is pain in the vicinity of the tumour. The discomfort may not initially be constant at first. If you have a tumour in a leg bone, it could grow worse at night or when you utilise the bone, as when you walk. The discomfort may intensify with activities and become more consistent with time.
People of all ages are susceptible to the metastatic illness known as bone cancer. In order to effectively treat the cancer and protect the surrounding healthy organs and tissues, localised medication delivery at the cancer site is necessary. The creation of calcium phosphate cements (CPCs) for the treatment of a wide range of ailments, including osteoporosis, osteoarthritis, osteomyelitis, and other musculoskeletal problems, is covered in a significant number of published studies, according to a thorough literature search. CPCs have only been used in a small number of studies especially to treat bone cancer [1-5].
KeywordsBone cancer; Bone cancer pain; Cancer
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi